| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash flows from financing activities | 30,615 | 30,615 |
| Net change in cash, cash equivalents and restricted cash | 18,297 | 21,617 |
| Cash and cash equivalents at beginning of period | 20,104 | - |
| Cash and cash equivalents at end of period | 38,401 | - |
ClearPoint Neuro, Inc. (CLPT)
ClearPoint Neuro, Inc. (CLPT)